Year archive

NervGen Pharma Corp. — 2024 filings

All 57 regulatory filings released by NervGen Pharma Corp. (NGEN) in 2024, sourced directly from the official regulator.

57 Filings

2024 Period

2024 filings (57)

Filing	Released	Lang
News release - English.pdf Share Issue/Capital Change	2024-12-20	English
Other material contract(s).pdf Capital/Financing Update	2024-12-20	English
Consent letter of issuer's legal counsel.pdf Capital/Financing Update	2024-12-20	English
Prospectus (non pricing) supplement (ATM) – English.pdf Share Issue/Capital Change	2024-12-20	English
Consent letter of underwriters' legal counsel.pdf Regulatory Filings	2024-12-20	English
News release - English.pdf Regulatory Filings	2024-11-14	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-11-14	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-11-14	English
Interim MD&A - English.pdf Regulatory Filings	2024-11-14	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-11-14	English
Decision Document (Preliminary).pdf Regulatory Filings	2024-11-04	English
Preliminary short form prospectus – English.pdf Regulatory Filings	2024-11-04	English
Decision Document / Order for Application - French.pdf Regulatory Filings	2024-10-31	English
News release - English.pdf Regulatory Filings	2024-09-30	English
News release - English.pdf Regulatory Filings	2024-09-20	English
News release - English.pdf Regulatory Filings	2024-08-22	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-08-22	English
Interim MD&A - English.pdf Regulatory Filings	2024-08-22	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-08-22	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-08-22	English
News release - English.pdf Regulatory Filings	2024-08-06	English
News release - English.pdf Regulatory Filings	2024-08-02	English
Material change report - English.pdf Regulatory Filings	2024-07-24	English
News release - English.pdf Regulatory Filings	2024-07-22	English
News release - English.pdf Regulatory Filings	2024-06-25	English
News release - English.pdf Regulatory Filings	2024-06-07	English
News release - English.pdf Regulatory Filings	2024-06-05	English
News release - English.pdf Regulatory Filings	2024-05-17	English
News release - English.pdf Regulatory Filings	2024-05-16	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-16	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-16	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-05-16	English
Interim MD&A - English.pdf Regulatory Filings	2024-05-16	English
News release - English.pdf Regulatory Filings	2024-05-07	English
Other.pdf Regulatory Filings	2024-05-06	English
Other.pdf Regulatory Filings	2024-05-06	English
Form of proxy - English.pdf Regulatory Filings	2024-05-06	English
News release - English.pdf Regulatory Filings	2024-04-17	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-04-17	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-04-17	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-04-17	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-04-17	English
Annual MD&A - English.pdf Regulatory Filings	2024-04-17	English
Audited annual financial statements – English.pdf Regulatory Filings	2024-04-17	English
Auditors' consent letter.pdf Regulatory Filings	2024-03-26	English
Other.pdf Regulatory Filings	2024-03-26	English
Other.pdf Regulatory Filings	2024-03-26	English
Other.pdf Regulatory Filings	2024-03-26	English
Other.pdf Regulatory Filings	2024-03-26	English
Other.pdf Regulatory Filings	2024-03-26	English
Auditors' consent letter.pdf Regulatory Filings	2024-03-26	English
Underwriting or agency agreements (or amendment thereto).pdf Regulatory Filings	2024-03-26	English
Prospectus (non pricing) supplement (other than ATM) – English.pdf Regulatory Filings	2024-03-26	English
Consent letter of underwriters' legal counsel.pdf Regulatory Filings	2024-03-26	English
Consent letter of issuer's legal counsel.pdf Regulatory Filings	2024-03-26	English
Material change report - English.pdf Regulatory Filings	2024-02-22	English
News release - English.pdf Regulatory Filings	2024-02-15	English